European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022Claus Garbe, Paul Lorigan, Giovanni Pellacani et al.|European Journal of Cancer|2022Cited by 320
European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022Claus Garbe, Paul Lorigan, Teresa Amaral et al.|European Journal of Cancer|2022Cited by 287
Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trialNicole Basset‐Séguin, Johan Hansson, Axel Hauschild et al.|European Journal of Cancer|2017Cited by 284
Guidelines on the use of extracorporeal photopheresisRobert Knobler, Uwe Hillen, Gösta Berlin et al.|Journal of the European Academy of Dermatology and Venereology|2013Cited by 218
Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trialMichele Maio, Bohuslav Melichar, Karl D. Lewis et al.|The Lancet Oncology|2018Cited by 216